Cargando…

Emergency Cardiac Surgery in Patients on Direct Oral Anticoagulants

Detalles Bibliográficos
Autores principales:	De Paulis, Stefano, Bruno, Piergiorgio, Massetti, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043443/ https://www.ncbi.nlm.nih.gov/pubmed/35497997 http://dx.doi.org/10.3389/fcvm.2022.884076

Ejemplares similares

Anticoagulation Management in High Bleeding-Risk ECMO in Adults
por: De Paulis, Stefano, et al.
Publicado: (2022)

Effect of a Novel Pocket Compression Device on Hematomas Following Cardiac Electronic Device Implantation in Patients Receiving Direct Oral Anticoagulants
por: Fei, Ye-Ping, et al.
Publicado: (2022)

The impact of direct oral anticoagulants on viscoelastic testing – A systematic review
por: Sahli, Sebastian D., et al.
Publicado: (2022)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
por: Liu, Xuyang, et al.
Publicado: (2022)

Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
por: Guo, Guigao, et al.
Publicado: (2022)

Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients
por: Iaccarino, Guido, et al.
Publicado: (2021)

Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines
por: Pastori, Daniele, et al.
Publicado: (2021)

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact
por: Cariou, Eve, et al.
Publicado: (2021)

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
por: Choi, Ju Hee, et al.
Publicado: (2022)

Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Elfar, Sohil, et al.
Publicado: (2022)

Safety and Effectiveness of Direct Oral Anticoagulants vs. Warfarin in Patients With Atrial Fibrillation and Endoscopy-Diagnosed Peptic Ulcer
por: Wang, Chun-Li, et al.
Publicado: (2021)

Safety and efficacy of direct oral anticoagulants in bioprosthetic valves: A systematic review and meta-analysis
por: Bakr, Lubna, et al.
Publicado: (2023)

Effects of oral anticoagulant therapy in patients with pulmonary diseases
por: Lai, Jiying, et al.
Publicado: (2022)

Increased Prevalence of Elevated D-Dimer Levels in Patients on Direct Oral Anticoagulants: Results of a Large Retrospective Study
por: Reda, Sara, et al.
Publicado: (2022)

Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2022)

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review
por: Adelakun, Adenike R, et al.
Publicado: (2023)

Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis
por: Yan, Yi-Dan, et al.
Publicado: (2020)

Comparative Risks of Fracture Among Direct Oral Anticoagulants and Warfarin: A Systematic Review and Network Meta-Analysis
por: Tsai, Sung Huang Laurent, et al.
Publicado: (2022)

Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF
por: McManus, David D., et al.
Publicado: (2019)

Association of Direct Oral Anticoagulants vs. Vitamin K Antagonists With Fractures in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
por: Wu, Xiaojuan, et al.
Publicado: (2021)

Effects of direct oral anticoagulants vs. vitamin K antagonists on acute kidney injury in patients with atrial fibrillation: A systematic review
por: Ren, Chengfa, et al.
Publicado: (2023)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Bitar, Yasmin de Souza Lima, et al.
Publicado: (2021)

Effectiveness of Direct Oral Anticoagulants in Obese Adults With Atrial Fibrillation: A Systematic Review of Systematic Reviews and Meta-Analysis
por: Shaikh, Fahad, et al.
Publicado: (2021)

The safety and efficacy of direct oral anticoagulants among chronic kidney disease patients on dialysis with non-valvular atrial fibrillation: a meta-analysis
por: Mapili, Jerahmeel Aleson L., et al.
Publicado: (2023)

Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016
por: Maura, Géric, et al.
Publicado: (2019)

Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
por: Wang, Mei, et al.
Publicado: (2022)

Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study
por: Pratt, Nicole L, et al.
Publicado: (2019)

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2022)

Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four post-hoc Analyses of Randomized Clinical Trials
por: Liu, Fuwei, et al.
Publicado: (2022)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2022)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
por: Li, Wenhao, et al.
Publicado: (2022)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Evolving technology: the TRIFLO tri-leaflet mechanical valve without oral anticoagulation: a potential major innovation in valve surgery
por: Carrel, Thierry, et al.
Publicado: (2023)

Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nationwide cohort study
por: Wu, Hsin-Hsu, et al.
Publicado: (2022)

Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage
por: Liu, Xin, et al.
Publicado: (2022)

Impact of self-funding on patient experience of oral anticoagulation self-monitoring: a qualitative study
por: Tompson, Alice, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_per4mvd4gkv7qv43vcjgefk3o3